BioWednesday: Addressing the Growing Pains in Life Sciences Companies

We are seeing some exciting developments in the Life Science sector and among the fast growing Stevenage BioScience Catalyst (SBC) companies. Significant venture funding rounds, clinical development progress of lead programmes and scaling of excellent supply chain providers as the sector grows are all creating very positive news flow. Success does not come without it’s challenges however, and the transition from start-up to scale up, pre-clinical to clinical or discovery to development can prove intense in order to keep  investors, clients and staff happy. We will hear exemplars from SBC occupiers of this growing success story and debate how they are addressing the challenges that come with such growth.

Programme:

12.00 - Registration and Lunch

12.30 - Welcome from 2B Scientific
Professor Andrew Mearns Spragg, Jellagen Marine Biotechnologies 

12.40 - Panel Discussion - Addressing the Growing Pains in Life Sciences Companies

Chair
Charles Large, Autifony

Panellists
Eddy Littler, ReViral
Mary Kerr, NeRRe Therapeutics & KaNDy Therapeutics
Robert de Jonge, Black Belt Therapeutics 
Mahendra, Deonarain, Antikor

13.50 - One Nucleus Corporate Sponsor introduction from Charles Stanley
Will Walter-Arnott, Charles Stanley

14.00 - Close